Annis Gardner Whiting Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-135
Closed -$28.5K 473
2026
Q1
$28.5K Buy
135
+9
+7% +$1.94K ﹤0.01% 671
2025
Q4
$25.9K Buy
126
+10
+9% +$1.88K ﹤0.01% 616
2025
Q3
$18.2K Sell
116
-17
-13% -$2.63K ﹤0.01% 620
2025
Q2
$22.3K Buy
133
+38
+40% +$5.64K 0.01% 548
2025
Q1
$13.1K Hold
95
0.01% 508
2024
Q4
$11.2K Buy
95
+42
+79% +$4.9K ﹤0.01% 519
2024
Q3
$5.86K Hold
53
﹤0.01% 617
2024
Q2
$5.21K Hold
53
﹤0.01% 771
2024
Q1
$5.96K Hold
53
﹤0.01% 741
2023
Q4
$5.37K Hold
53
﹤0.01% 540
2023
Q3
$4.6K Buy
+53
New +$4.79K ﹤0.01% 539

Other funds holding CAH

Annis Gardner Whiting Capital Advisors's CAH Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 135 shares — an estimated $28.5K sold.

Annis Gardner Whiting Capital Advisors first reported a position in CAH in Q3 2023 and held it in 11 quarters. The position peaked at $28.5K in Q1 2026. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 135 Cardinal Health shares in Q2 2026, an estimated $28.5K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Cardinal Health in Q3 2023 and held it in 11 quarters.
  • Annis Gardner Whiting Capital Advisors's Cardinal Health position peaked at $28.5K in Q1 2026.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.